Skip to main content
. 2016 Mar 17;6(3):237–250. doi: 10.1159/000444094

Table 1.

Characteristics of 14 studies analyzing risk factors associated with cardiac surgery with CPB

First author [Ref.] Year Country Race Source Study type Sample size (case/control) Risk factor Quality evaluation
Suen [13] 1998 China Hong Kong Asia hospital case-controlled 67/380 1, 2, 7, 11, 13, 14, 16, 20 6
Sirvinskas [14] 2008 US US hospital case-controlled 19/160 1, 6, 10, 12 6
Haase [15] 2012 English Europe hospital case-controlled 179/741 1–11, 15, 16, 20 6
Rodrigues [16] 2009 Brazil South America hospital case-controlled 78/691 2, 4, 6–10, 13, 14, 16, 17, 19, 21 7
Ilknur [17] 2005 Turkey Asia hospital case-controlled 168/14,269 2, 3, 6, 10–13, 15, 16, 18, 20 7
Bove [18] 2004 Italy Europe hospital case-controlled 171/4,897 1, 2, 5, 6, 8, 10, 11, 14–16 7
Thakar [19] 2005 US US hospital case-controlled 269/15,569 1, 2, 6, 8–11, 14–16, 18, 19 6
Loef [20] 2005 Holland Europe hospital case-controlled 145/698 1–7, 9–11, 14–20 7
Lin [21] 2009 China Asia hospital case-controlled 340/4,760 10, 12 6
Han [22] 2006 China Asia hospital case-controlled 108/152 7, 10, 12, 15 6
Yang [23] 2013 China Asia hospital case-controlled 83/129 1–4, 6, 7, 11, 17–19, 21 6
Englberger [24] 2013 Mayo Europe hospital case-controlled 115/836 2–4, 6, 8–10, 12, 13, 17–20, 21 7
Karkouti [25] 2009 Canada US hospital case-controlled 347/3,460 1–6, 8–11, 13, 15, 16, 19 7
Landoni [26] 2007 Italy Europe hospital case-controlled 68/3,035 2, 5, 6, 8, 10, 11, 13, 15, 16, 19, 20 7

Risk factors: 1 = any type of cardiac surgery; 2 = diabetes mellitus; 3 = hypertension; 4 = acute myocardial infarction; 5 = low cardiac output; 6 = age; 7 = NYHA class III/IV; 8 = respiratory system disease; 9 = peripheral vascular disease; 10 = CPB time; 11 = use of IABP; 12 = aortic clamping time; 13 = postoperative infection; 14 = congestive heart failure; 15 = redo operation; 16 = emergency operation; 17 = BMI; 18 = preoperative creatinine; 19 = cerebrovascular disease; 20 = mortality; 21 = EF.